| Corporate Overview |
| Investors |
| Board of Directors |
| Executive Management |
| R&D Strategy |
| Pipeline |
| Intellectual Property |
| Scientific Publications |
| Scientific Communications |
| Licensing Strategy |
| The Market |
| Contact |
| Careers |
|
|
|
|
||||||
|
|||||||
|
|||||||
| You are here: home |
|
|
|
|
||||||||||||||||||||||
| © 2006 Copyright Unibioscreen | Avenue Joseph Wybran, 40 | B-1070 Brussels | Belgium | + 32 (0)2 529 58 34 |
|
Cellular imaging (computer-assisted phase-contrast microscopy) of U373 human glioblastoma cells left untreated and observed for 72 hrs*.
Cellular imaging (computer-assisted phase-contrast microscopy) of U373 human glioblastoma cells treated with 10 nM UNBS1450 for 72 hrs*.